ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Liver transplantation"

  • 2019 American Transplant Congress

    Incisional Hernia Repair Post Liver and or Kidney Transplantation

    J. Buggs1, A. Brando2, J. Sokolich1, E. Rogers1, A. Kumar3, V. Bowers1

    1Tampa General Hospital, Tampa, FL, 2University of Tampa, Tampa, FL, 3University of South Florida, Tampa, FL

    *Purpose: The literature has demonstrated worse patient survival rates with incisional hernias in abdominal transplant patients. The purpose of this study was to evaluate patient…
  • 2019 American Transplant Congress

    Rituximab Desensitization to Liver Transplantaiton Recipients with Preformed Donor Specific Antibodies to Prevent Antibody Mediated Rejecton

    Y. Ogura, M. Shizuku, N. Kurata, K. Jobara, H. Kamei

    Transplantation Surgery, Nagoya University Hospital, Nagoya City, Japan

    *Purpose: Preformed donor-specific antibodies (DSA) are considered as a risk factor after solid organ transplantation. Strong DSA is associated with high mortality and increased risk…
  • 2019 American Transplant Congress

    Multicenter Experience Evaluating Outcomes of HCV-Seropositive Donors to HCV-Seronegative Recipients Liver Transplantation

    K. Wijarnpreecha1, B. Aqel2, S. Pungpapong1, C. Taner3, K. Reddy4, M. Leise5, R. Dickson2

    1Gastroenterology and Hepatology, Mayo Clinic, Jacksonville, FL, 2Gastroenterology and Hepatology, Mayo Clinic, Scottsdale, AZ, 3Transplant, Mayo Clinic, Jacksonville, FL, 4Transplant and Hepatobiliary Surgery, Mayo Clinic, Scottsdale, AZ, 5Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN

    *Purpose: Grafts from hepatitis C virus (HCV)-seropositive donors can now be considered for liver transplant (LT) due to the advent of direct-acting antiviral agents (DAA).…
  • 2019 American Transplant Congress

    Impact of the Pediatric End-Stage Liver Disease Growth Failure Threshold on Waitlist Mortality in Children Awaiting Liver Transplant

    S. M. Swenson, J. P. Roberts, S. Rhee, E. R. Perito

    University of California, San Francisco, San Francisco, CA

    *Purpose: To examine the impact on waitlist mortality of Pediatric End-Stage Liver Disease (PELD)’s incorporation of growth failure (GF) as a threshold variable—present or absent…
  • 2019 American Transplant Congress

    Evaluating Liver Regeneration during Normothermic Machine Perfusion in Hepatectomized Rat Liver Model

    M. Aburawi1, S. Mert1, E. Hafiz2, P. Mahboub1, H. Yeh1, K. Uygun1, J. Markmann1

    1Surgery, Massachusetts General Hospital, Boston, MA, 2Pathology and Electron Microscopy, Theodor Bilharz Research Institute, Cairo, Egypt

    *Purpose: Realizing the liver’s unique ability to regenerate, this ongoing study examines Normothermic Machine Perfusion (NMP) as a promising platform for evaluating & potentially simulating…
  • 2019 American Transplant Congress

    Outcomes of Liver Transplantation for Mixed Hepatocellular-Cholangiocarcioma

    M. Najjar1, K. Bruestle1, P. Jiang1, S. Robbins-Juarez1, R. Hwang1, A. Mathur1, E. C. Verna1, A. Griesemer1, B. Samstein1, T. Kato1, Y. M. Saenger1, K. J. Halazun2, J. C. Emond1

    1Columbia University Medical Center, New York, NY, 2Weill Cornell Medicine, New York, NY

    *Purpose: Mixed hepatocholangiocarcinomas (HCC-CCA) are rare tumors with both hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCA) differentiations. They are usually associated with a worse prognosis than…
  • 2019 American Transplant Congress

    HOPE in Action: A Multicenter Prospective Study of HIV to HIV Liver Transplantation

    C. Durand1, S. Florman2, M. Bowring3, D. Brown1, B. Haydel2, J. Hamilton1, P. Stock4, J. Price5, T. Pruett6, V. Kirchner7, D. Wojciechowksi8, N. Turgeon9, C. Wolfe10, V. Stosor11, J. Charette11, A. Cameron3, S. Ottmann3, S. Huprikar12, D. Segev3

    1Medicine, Johns Hopkins University, Baltimore, MD, 2Surgery, Mount Sinai, New York, NY, 3Surgery, Johns Hopkins University, Baltimore, MD, 4Surgery, University of California San Francisco, San Francisco, CA, 5Medicine, University of California San Francisco, San Francisco, CA, 6Surgery, University of Minnesota, Minneapolis, MN, 7Medicine, University of Minnesota, Minneapolis, MN, 8Medicine, Mass General Hospital, Boston, MA, 9Surgery, Emory University, Atlanta, GA, 10Medicine, Duke University, Durham, NC, 11Medicine, Northwestern University, Chicago, IL, 12Medicine, Mount Sinai, New York, NY

    *Purpose: HIV+ liver transplant (LT) candidates face higher mortality and lower access to transplant compared to HIV- counterparts. With the US HOPE Act, HIV+ donor…
  • 2019 American Transplant Congress

    A Randomized, Controlled, Trial of Interventions to Promote Walking after Abdominal Organ Transplantation: The LIFT Study

    M. Serper1, I. Barankay2, S. Chadha1, J. Shults3, P. Reese1

    1University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, 2Wharton School, University of Pennsylvania, Philadelphia, PA, 3Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, PA

    *Purpose: Substantial weight gain and sedentary behavior are common after transplantation. Behavioral economic strategies with financial incentives and reminders may promote healthy behaviors in the…
  • 2019 American Transplant Congress

    Loss of FXR Exacerbates Liver Damage by Activating NLRP3 Inflammasome Induced Pyroptosis in Liver Ischemia Reperfusion Injury

    Z. Zhu, Y. Zhang, Y. Tang, S. Huang, Q. Zhao, W. Ju, Z. Guo, X. He

    Organ Transplant Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China

    *Purpose: The relationships among Farnesoid X receptor (FXR), nucleotide-binding oligomerization domain-like receptor (NLR) family pyrin domain-containing 3 (NLRP3) inflammasome and pyroptosis are largely unknown in…
  • 2019 American Transplant Congress

    Risk Stratification of Patients Undergoing Simultaneous Liver Transplantation and Cardiac Surgery

    T. Diago Uso, G. D'Amico, S. Armanyous, L. Lomaglio, B. Eghtesad, M. Fujiki, F. Aucejo, K. Sasaki, N. K. Menon, M. Fares, M. Tong, K. Hashimoto, C. Miller, C. Quintini

    Cleveland Clinic, Cleveland, OH

    *Purpose: Evaluate risk factors and outcomes of combined liver transplantation (OLT) and cardiac surgery, including coronary artery grafting and valve replacement.*Methods: Between 1/2005 and 8/2018,…
  • « Previous Page
  • 1
  • …
  • 81
  • 82
  • 83
  • 84
  • 85
  • …
  • 180
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences